BREAKING BAD FANS IN FRENZY: Viral Internet Storm Puts RJ Mitte in Global Search Spotlight
Over 2 million searches surge for actor RJ Mitte as Breaking Bad fans ignite a massive viral trend celebrating Walter White Jr's enduring pop culture legacy.
Over 2 million searches surge for actor RJ Mitte as Breaking Bad fans ignite a massive viral trend celebrating Walter White Jr's enduring pop culture legacy.
Discover the latest updates on the DC gym shooting after Dr. Matt Lambert was identified as the gunman following a bitter HOA property dispute in Logan Circle.
Are $25,000 kayak fishing setups worth the hype? National champion Wyatt Hammond breaks down the costs and what beginners actually need to succeed.
The Department of Homeland Security announces that U.S. Immigration and Customs Enforcement carried out a record 483,000 deportations and 491,000 arrests in FY 2026.
NHTSA confirms the exact vehicle models included in the 635,808 Honda and Acura electric power steering recall, led by the 2023-2025 Honda Pilot and Acura MDX.
Former NFL head coach and television analyst Rex Ryan turns himself in on misdemeanor hit-and-run charges in downtown Nashville ahead of Week 11 NFL action.
Deep-dive original reporting on today's highest-velocity U.S. search queries
Discover why owning a pet financial plan is essential in 2026. Learn how to manage rising vet costs, build emergency funds, and evaluate pet insurance.
The Empire State Building daredevils speak out in an exclusive interview just days before their high-stakes Manhattan court date following a viral climb.
Discover how commercial restaurant composting initiatives in Franklin County are diverting food waste, cutting costs, and extending regional landfill lifespans.
Will Venable wins 2026 AL Manager of the Year after leading the Chicago White Sox in a historic 24-win turnaround and first playoff berth.
Elon Musk confirms Tesla Cybertruck production end by mid-2027. The Texas factory will pivot to Cybercab self-driving taxis as sales for the pickup decline.
New breast cancer drug trial results show 75% tumor shrinkage. Trastuzumab rezetecan outperformed chemotherapy in the HORIZON-Breast06 study for HER2-low patien